US-headquartered CDMO giant Catalent has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
14.06.2017
- US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
18.04.2017
- The US Food and Drug Administration (FDA) has approved NuvOx Pharma’s application to proceed with Phase 2 clinical trials for an Investigational New Drug (IND) to initiate a Phase...
27.02.2017
- The US Food and Drug Administration (FDA) has accepted Swiss pharmaceutical major Novartis’ supplemental New Drug Application (sNDA) for filing and granted priority review for the...
10.11.2016
- UPS has entered into a definitive purchase agreement to acquire Marken, a global provider of supply chain solutions to the life sciences industry. The transaction, which provides...
25.05.2016
- France's health ministry has presented a plan to tighten rules governing human drug trials after a trial in Rennes in January of this year led to the death of one volunteer and...
28.04.2016
- As part of a newly announced collaboration with non-profit scientific institutes and high-tech companies, British-Swedish drugmaker AstraZeneca and its global biologics research...
